ADVM · Categories · Form 4
ADVM - SEC Form 4 insider transactions
Adverum Biotechnologies Inc. (ADVM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ADVM
- CEO, PRESIDENT AND DIRECTOR Fischer Laurent exercised 150,000 shares at a strike of $4.20 and was granted 500,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF OPERATING OFFICER Soparkar Peter was granted 150,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Chief Medical Officer Ozden Rabia Gurses was granted 85,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF DEVELOPMENT OFFICER Seyedkazemi Setareh was granted 85,000 units of Common Stock - Performance Stock Units, closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF FINANCIAL OFFICER Rubinstein Linda M was granted 42,000 units of Common Stock - Performance Stock Units and exercised 48,750 shares at a strike of $4.20, closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Hong Soo4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Whitcup Scott M4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Tuckson Reed Vaughn4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Director Svoronos Dawn closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Director Scopa James Paul closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Nicholson, C. David4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Director Lupher, Jr. Mark L. closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Director Machado Patrick closing all direct ownership in the company (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Kiss Szilard4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Large owner Frazier Life Sciences Public Fund, L.P.4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Large owner Leonard Braden Michael sold $2,200,372 worth of shares (524,560 units at $4.19) (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Large owner Leonard Braden Michael sold $2,407,833 worth of shares (574,886 units at $4.19) (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CHIEF OPERATING OFFICER Soparkar Peter4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Seyedkazemi Setareh4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Rubinstein Linda M4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Ozden Rabia Gurses4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CEO, PRESIDENT AND DIRECTOR Fischer Laurent4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Kiss Szilard4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Scopa James Paul4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Whitcup Scott M4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Tuckson Reed Vaughn4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Svoronos Dawn4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Lupher, Jr. Mark L.4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Hong Soo4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Nicholson, C. David4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Machado Patrick4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF OPERATING OFFICER Soparkar Peter sold $5,920 worth of shares (2,960 units at $2.00), decreasing direct ownership by 7% to 39,154 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF DEVELOPMENT OFFICER Seyedkazemi Setareh sold $1,848 worth of shares (924 units at $2.00), decreasing direct ownership by 6% to 13,768 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CEO, PRESIDENT AND DIRECTOR Fischer Laurent sold $18,252 worth of shares (9,126 units at $2.00), decreasing direct ownership by 9% to 87,488 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF OPERATING OFFICER Soparkar Peter was granted 13,125 shares, increasing direct ownership by 45% to 42,114 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF FINANCIAL OFFICER Rubinstein Linda M was granted 8,125 shares, increasing direct ownership by 73% to 19,325 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CHIEF DEVELOPMENT OFFICER Seyedkazemi Setareh was granted 8,125 shares, increasing direct ownership by 124% to 14,692 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- Chief Medical Officer Ozden Rabia Gurses was granted 8,125 shares (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- CEO, PRESIDENT AND DIRECTOR Fischer Laurent was granted 25,000 shares, increasing direct ownership by 35% to 96,614 units (SEC Form 4)4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Ozden Rabia Gurses4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Rubinstein Linda M4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Seyedkazemi Setareh4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CHIEF OPERATING OFFICER Soparkar Peter4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by CEO, PRESIDENT AND DIRECTOR Fischer Laurent4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Ozden Rabia Gurses4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Nicholson, C. David4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Hong Soo4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Lupher, Jr. Mark L.4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Svoronos Dawn4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Tuckson Reed Vaughn4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Whitcup Scott M4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Scopa James Paul4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Machado Patrick4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Director Kiss Szilard4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Seyedkazemi Setareh4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Soparkar Peter4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Fischer Laurent4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Seyedkazemi Setareh4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Fischer Laurent4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)
- SEC Form 4 filed by Rubinstein Linda M4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)